Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Remember that clinical trials failed to demonstrate statistically significant weight loss in the largest study, leading to development termination in 2007
Therefore, these findings support a detrimental role of HO-1 activation in the settings of sI/R and doxorubicin insults, where HO-1 is markedly upregulated, by promoting ferroptosis of cardiomyocytes
1997 Oct [cited 2019 Jul 19];87:76570
In rat coronary artery smooth muscle cells, treatment with liraglutide inhibited VSMC phenotypic transition induced by advanced glycation end products (AGEs), through blocking the nuclear factor-B (NF-B) signaling pathway and activating the protein kinase A (PKA) signaling pathway
Clinical Studies Clinical Studies in Adults The effect of QSYMIA on weight loss in conjunction with reduced caloric intake and increased physical activity was studied in two randomized, double-blind, placebo-controlled studies in patients with obesity (Study 1) and patients with obesity or overweight with two or more significant co-morbidities (Study 2)
